✦ LIBER ✦

500 Concurrent low-dose daily carboplatin (CBDCA) and hyperfractionated radiotherapy (HFX-RT) in stage III non-small cell lung cancer (NSCLC)

✍ Scribed by Yoshida, Y.; Kashiwado, K.; Suenaga, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent carboplatin (CBDCA) and Radio

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Concurrent carboplatin (CBDCA) and radio

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Concurrent daily carboplatin (CBDCA) and

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Hyperfractionated radiation therapy (HFX

✍ Jeremic, B.; Djuric, Lj.; Jevremovic, S.; Matovic, M.; Shibamoto, Y. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Hyperfractionated radiation therapy (HFX

✍ Jeremic, B.; Djuric, Lj.; Jevremovic, S.; Shibamoto, Y. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 185 KB

1051 Pretreatment prognostic factors in

✍ Jeremic, B.; Shibamoto, Y.; Acimovic, Lj.; Milisavljevic, S. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB